Discussion
Takhzyro (lanadelumab) is a safe and effective long-term preventive treatment that can reduce the frequency of hereditary angioedema (HAE) attacks and improve disease control and quality of life, according to a review of clinical and real-world data. The review, “Lanadelumab Use for Hereditary Angioedema Long-Term…